Pricing

Free through Q3 2026. Founding subscribers lock the founding rate for the life of the subscription.

Everything is free through the end of 2026. Coverage Alpha publishes through Q3 earnings season at no cost. Paid subscriptions open in January 2027, timed to the national formulary template drops. Anyone on the list before then is a founding subscriber.

Individual
$199
per month, from January 2027
Annual: $1,990 — two months free
  • Every issue, within 48 hours of the call
  • Full nine-company coverage universe
  • Interim issues on formulary and policy events
  • Complete searchable archive
Founding rate
$99
per month, locked for life
Available only before January 2027
  • Everything in the Individual tier
  • Rate locked for the life of the subscription
  • Free access through all of 2026
  • Direct line to the author on coverage requests
Team
$995
per month, five seats
Additional seats available
  • Everything in the Individual tier, for five people
  • Internal distribution rights within the licensed team
  • The underlying Excel workbooks: WAC tracker, franchise revenue builds, gross-to-net sensitivities
  • One coverage request per quarter

A Pro tier is coming

An individual Pro tier at $349 per month will add the Excel workbooks that sit behind each issue — the WAC tracker, franchise revenue builds, and gross-to-net sensitivity models — for subscribers who want the underlying analysis rather than only the conclusions. It launches alongside paid access in January.

Common questions

Why free until January?

Because research is bought on track record, not promises. Publishing through an entire earnings season gives you an archive to judge before anyone is asked to pay, and gives the publication time to prove it can hold the 48-hour cadence under real conditions.

What does "locked for life" actually mean?

The founding rate holds for as long as the subscription remains active and uninterrupted. If list pricing rises later — and it likely will as the coverage universe and the workbook library expand — founding subscribers stay at $99.

Can I expense this?

That is the design intent. Both the individual and founding tiers sit below the threshold at which most organizations require additional approval, and an invoice suitable for expense submission is provided automatically.

What if I only care about one company?

Single-company coverage is not offered, deliberately. The value of the brief is comparative. One company's pricing doctrine sets the terms every competitor in that category has to negotiate against, and that read-through is the analysis worth paying for. A brief that covered your company alone would tell you what you already know.

Free through Q3 2026 earnings season

Join the founding list.

Every issue free through the end of the year. Founding subscribers lock $99/month for the life of the subscription when paid access opens in January 2027.

Independent publication. Not investment advice. Unsubscribe anytime.